ALS biotech Amylyx Pharmaceuticals has grown with CFO Frates’ help


Amylyx Pharmaceuticals has been on a tear since Jim Frates joined the Cambridge firm early in 2021.

Previous Ellis had led Flywire through major milestones
Next Albertelli helped lift Draper Lab to its best financial year